Risk Factors of Very Severe RSV Infections in a Multicenter Cohort of Very Preterm and Extreme Preterm Babies Receiving or Not Palivizumab

Risk Factors of Very Severe RSV Infections in a Multicenter Cohort of Very Preterm and Extreme Preterm Babies Receiving or Not Palivizumab

IntroductionPreterm infants are at risk of lower respiratory tract infections (LRTI), including Respiratory Syncytial Virus (RSV) associated bronchiolitis, for which palivizumab prophylaxis can be proposed. Our aim was to determine risk factors of very severe RSV disease in children born before 34 w...

Descrizione completa

Dettagli Bibliografici
Autori principali: Gwenaelle Mulot, Mehdi Benchaib, Frank Plaisant, Dominique Ploin, Yves Gillet, Etienne Javouhey, Olivier Claris, Jean-Charles Picaud, Jean-Sebastien Casalegno, Marine Butin
Natura: Articolo
Lingua:English
Pubblicazione: Frontiers Media S.A. 2022-07-01
Serie:Frontiers in Pediatrics
Soggetti:
cohort study
RSV
bronchiolitis
preterm
palivizumab
LRTI
Accesso online:https://www.frontiersin.org/articles/10.3389/fped.2022.884120/full

Accesso online

https://www.frontiersin.org/articles/10.3389/fped.2022.884120/full

Documenti analoghi